Axonics PE Ratio 2017-2024 | AXNX
Current and historical p/e ratio for Axonics (AXNX) from 2017 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Axonics PE ratio as of September 19, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Axonics PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-09-20 | 69.15 | 0.00 | |
| 2024-06-30 | 67.23 | $-0.04 | 0.00 |
| 2024-03-31 | 68.97 | $-0.32 | 0.00 |
| 2023-12-31 | 62.23 | $-0.13 | 0.00 |
| 2023-09-30 | 56.12 | $-0.25 | 0.00 |
| 2023-06-30 | 50.47 | $-0.67 | 0.00 |
| 2023-03-31 | 54.56 | $-0.99 | 0.00 |
| 2022-12-31 | 62.53 | $-1.30 | 0.00 |
| 2022-09-30 | 70.44 | $-1.65 | 0.00 |
| 2022-06-30 | 56.67 | $-1.69 | 0.00 |
| 2022-03-31 | 62.60 | $-1.81 | 0.00 |
| 2021-12-31 | 56.00 | $-1.88 | 0.00 |
| 2021-09-30 | 65.09 | $-1.83 | 0.00 |
| 2021-06-30 | 63.41 | $-1.69 | 0.00 |
| 2021-03-31 | 59.89 | $-1.64 | 0.00 |
| 2020-12-31 | 49.92 | $-1.50 | 0.00 |
| 2020-09-30 | 51.04 | $-1.96 | 0.00 |
| 2020-06-30 | 35.11 | $-2.61 | 0.00 |
| 2020-03-31 | 25.41 | $-2.75 | 0.00 |
| 2019-12-31 | 27.71 | $-2.79 | 0.00 |
| 2019-09-30 | 26.92 | $-2.54 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $3.540B | $0.366B |
| Axonics Modulation Technologies Inc. is focused on development and commercialization of a novel implantable SNM system for patients with urinary and bowel dysfunction and disrupting the SNM market. Axonics Modulation Technologies Inc. is based in Irvine, CA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $41.383B | 22.26 |
| Tempus AI (TEM) | United States | $7.730B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $6.325B | 1178.33 |
| Hims & Hers Health (HIMS) | United States | $3.634B | 211.50 |
| 10x Genomics (TXG) | United States | $2.829B | 0.00 |
| Enovis (ENOV) | United States | $2.514B | 18.23 |
| Azenta (AZTA) | United States | $2.421B | 137.50 |
| Privia Health (PRVA) | United States | $2.324B | 162.00 |
| IRhythm Technologies (IRTC) | United States | $2.283B | 0.00 |
| Omnicell (OMCL) | United States | $1.997B | 65.79 |
| Schrodinger (SDGR) | United States | $1.517B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.507B | 0.00 |
| Phreesia (PHR) | United States | $1.373B | 0.00 |
| Standard BioTools (LAB) | United States | $0.783B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.693B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.567B | 481.00 |
| Health Catalyst (HCAT) | United States | $0.534B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.408B | 0.00 |
| Talkspace (TALK) | United States | $0.353B | 0.00 |
| Pulmonx (LUNG) | United States | $0.336B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.277B | 0.00 |
| TruBridge (TBRG) | United States | $0.184B | 13.49 |
| P3 Health Partners (PIII) | United States | $0.160B | 0.00 |
| American Well (AMWL) | United States | $0.149B | 0.00 |
| Augmedix (AUGX) | United States | $0.115B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.084B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
| HeartBeam (BEAT) | United States | $0.056B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.054B | 0.00 |
| 111 (YI) | China | $0.053B | 0.00 |
| Zepp Health (ZEPP) | China | $0.049B | 0.00 |
| CareCloud (CCLD) | United States | $0.047B | 0.00 |
| Movano (MOVE) | United States | $0.036B | 0.00 |
| Outset Medical (OM) | United States | $0.031B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.024B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.023B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.019B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.018B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.012B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.006B | 0.00 |
| HeartSciences (HSCS) | United States | $0.003B | 0.00 |
| Syra Health (SYRA) | United States | $0.003B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |